Acute Liver Injury Caused by Intravenous Amiodarone;Myoclonus Associated with Long-term Use of Diltiazem;Involuntary Movements Associated with Cetirizine;Cocaine-Induced Ischemic Bowel;Asenapine and Severe Allergic Reactions;Dapsone-Induced Methemoglobinemia;Neurotoxic Effects Associated with Antibiotic Use

2011 ◽  
Vol 46 (11) ◽  
pp. 835-838
Author(s):  
Sinister Joel

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MEDWATCH program (800-FDA-1088). If you have reported an interesting, preventable ADR to MEDWATCH, please consider sharing the account with our readers.

2016 ◽  
Vol 51 (11) ◽  
pp. 884-887
Author(s):  
Michael A. Mancano

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.


2020 ◽  
Vol 14 (1) ◽  
pp. 87-90
Author(s):  
Rajesh Essrani ◽  
Shehriyar Mehershahi ◽  
Rajesh Kumar Essrani ◽  
Shri Jai Kirshan Ravi ◽  
Sajeer Bhura ◽  
...  

Amiodarone is a lipophilic structure with a half-life of 25–100 days. Long-term oral amiodarone is associated with photosensitivity, thyroid dysfunction, and pulmonary and hepatic toxicity. Intravenous amiodarone can lead to sweating, heating sensation, nausea, phlebitis at the injection site, and rarely acute hepatitis. This is a compelling case of a 60-year-old male who developed acute liver injury 24–36 h after starting amiodarone. All the possible causes of acute liver injury were ruled out, and his liver enzymes improved after discontinuing amiodarone.


2017 ◽  
Vol 11 (2) ◽  
pp. 440-445 ◽  
Author(s):  
Jenny Sarah Schneider ◽  
Matteo Montani ◽  
Felix Stickel

Adverse drug reactions are among the most frequent side effects of synthetic and complementary alternative drugs and represent the premier causes of license revocations and acute liver failure. Drug-induced liver injury can resemble literally any other genuine liver disease and usually responds well to drug dechallenge. However, in some cases autoimmune-like hepatitis can evolve, requiring short- and sometimes long-term immunosuppression. Here, we present the hitherto first case of autoimmune-like hepatitis following treatment with zoledronic acid.


Hepatology ◽  
2015 ◽  
Vol 62 (4) ◽  
pp. 1070-1085 ◽  
Author(s):  
Binxia Chang ◽  
Ming-Jiang Xu ◽  
Zhou Zhou ◽  
Yan Cai ◽  
Man Li ◽  
...  

2017 ◽  
Vol 11 (3) ◽  
pp. 564-568 ◽  
Author(s):  
Qin Rao ◽  
Isaiah Schuster ◽  
Talal Seoud ◽  
Kevin Zarrabi ◽  
Nirvani Goolsarran

Nafcillin-induced acute liver injury is a rare and potentially fatal complication that has been known since the 1960s but inadequately studied. At this time, the only proven treatment is early discontinuation of the drug. Because of the high prevalence of nafcillin class antibiotic use in the United States, it is important for clinicians to have a high clinical suspicion for this diagnosis. We present a case of liver failure attributable to nafcillin use in a 68-year-old male with a history methicillin-sensitive Staphylococcus and L3/L4 osteomyelitis. After starting long-term antibiotic therapy, he presented with painless jaundice which necessitated discontinuation of the drug. At the time of presentation, the patient’s lab work exhibited a bilirubin/direct bilirubin of 9.4/8.2 mg/dL, alkaline phosphatase of 311 IU/L, and aspartate transaminase/alanine transaminase of 109/127 IU/L. The patient was switched to i.v. vancomycin given the concern for drug-induced liver injury. Imaging did not show obstruction of the hepatobiliary or pancreaticobiliary trees. Serology was unremarkable for viral etiology, autoimmune processes, Wilson disease, and hemochromatosis. A liver biopsy showed findings consistent with drug-induced liver injury. The patient’s liver function tests peaked at day 7 of admission and trended towards normal levels with cessation of nafcillin therapy. The patient was discharged with a diagnosis of nafcillin-induced acute liver injury. Our case highlights the importance of early recognition of the diagnosis and careful monitoring of liver function when nafcillin is employed in the clinical setting.


2011 ◽  
Vol 29 (7) ◽  
pp. 843.e5-843.e6 ◽  
Author(s):  
Andrea Verhovez ◽  
Fabrizio Elia ◽  
Alessandra Riva ◽  
Giovanni Ferrari ◽  
Franco Aprà

PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0212394 ◽  
Author(s):  
Herbert L. Bonkovsky ◽  
Huiman X. Barnhart ◽  
David M. Foureau ◽  
Nury Steuerwald ◽  
William M. Lee ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (10) ◽  
pp. e0206389 ◽  
Author(s):  
Herbert L. Bonkovsky ◽  
Huiman X. Barnhart ◽  
David M. Foureau ◽  
Nury Steuerwald ◽  
William M. Lee ◽  
...  

2019 ◽  
Vol 114 (1) ◽  
pp. S1701-S1702 ◽  
Author(s):  
Rajarajeshwari Ramachandran ◽  
Ramachandra Bongu ◽  
Allison Ajluni ◽  
Niraj Jani

Sign in / Sign up

Export Citation Format

Share Document